Trial size AKT2 antibodies available in the Antibody Validation Project

Posted by M.Popov on 12th Nov 2020

Trial size AKT2 antibodies available in the Antibody Validation Project

Trial size AKT2 antibodies available in the Antibody Validation Project

Introduction:

AKT serine/threonine kinase 2(AKT2) is protein made from the AKT2 oncogene and is mainly involved in signalling pathways including the Insulin signalling, but defects in it cause non-insulin-dependent diabetes and several types of cancer. Furthermore, being a potential drug target many new uses for it can be found. We provide a number of trial sized antibodies, which are suitable for AKT2 research purposes, and to help you make the right decision and find the best suited antibody for you, please find the answers to some of the key topics regarding AKT2 that we have provided in the links below.

What is AKT2?

AKT2 is a putative oncogene which encodes a protein from the serine/threonine subfamily of kinases, which are involved in signalling pathways. The AKT2-related protein is a general protein kinase which phosphorylates several other proteins and is also implicated in Insulin signalling.

Where is AKT2 found?

On cellular level, AKT2 can be found both in the nucleus and cytoplasm, and having low tissue specificity, it is detected in all tissues throughout the human body.

What role does AKT2 play in disease?

Being an oncogene, AKT2 takes part in the tumorigenesis of cancer cells, furthermore, its over expression contributes to the maligant phenotype of a subgroup of human ductal pancreatic cancers. Apart from that, defects in AKT2 are proved to cause susceptibility to breast cancer and insulin-related diseases such as NIDDM and HIHGHH.

AKT2 antibodies in the Antibody Validation project

St John's Laboratory offers a variety of trial size primary antibodies which target AKT2, which are available to try through the Antibody Validation Project. Below we highlight those which have already been reviewed, as well as others which are available to try.

Customer reviewed AKT2 antibodies

ModelNameHostClonalityRatingApplication Tested
STJ97469Anti-AKT2 antibodyRabbitPolyclonal4WB

Other AKT2 antibodies available in the Antibody Validation Project

ModelNameHostClonalityRecommended Applications
STJ90169Anti-Phospho-Akt2 (S474) antibodyRabbitPolyclonalWB,IHC,ELISA
STJ97821Anti-Akt2 antibodyMouseMonoclonalWB,IHC,IF,ELISA
ModelNameHostClonalityRecommended Applications
STJ113438Anti-AKT2 AntibodyMouseMonoclonalWB,IHC,FC,IF,IP,ChIP
STJ118023Anti-AKT2 AntibodyRabbitPolyclonalWB,IHC,IF
STJ22015Anti-Phospho-AKT2-(S474) AntibodyRabbitPolyclonalWB
STJ22016Anti-Phospho-AKT2-(S474) AntibodyRabbitPolyclonalWB,IHC
STJ22573Anti-AKT2 AntibodyRabbitPolyclonalWB,IF
STJ70714Anti-AKT2 AntibodyGoatPolyclonalELISA,WB

How does the Antibody Validation Project work?

In order to help our customers with their choice of antibody with low risk, we offer one of the largest ranges of primary antibodies with trial size options available.

The Antibody Validation Project works like this.
1. Order your trial size antibody online.
2. Explore its suitability.
3. Return your results by posting them on the product page.
4. Receive a sample refund.

Find out more here.